FDA approval for Glenmark's generic drug

Glenmark gets the US health regulator nod for generic diabetes treatment drug

id-100288878

The approval is for strengths of 0.1 mg and 0.2 mg

Glenmark Pharmaceuticals has said that the US Food and Drug Administration (US FDA) has approved its generic version of desmopressin acetate tablets used in the treatment of diabetes and bed-wetting.

The approval is for strengths of 0.1 mg and 0.2 mg.

Desmopressin acetate is sold under the trademark DDAVP by Ferring Pharmaceuticals. Accordint to IMS data, DDAVP market achieved annual sales of approximately $72.1million in the 12 month period ended March 2015.

 

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email

X